Premium
PBPC mobilization with chemotherapy and G–CSF in patients with chronic myeloid leukemia: quantification of bcr/ abl ‐positive cells by interphase fluorescence in situ hybridization and competitive PCR
Author(s) -
Keil Felix,
Mitterbauer Gerlinde,
Chen Xiao,
Haas Oskar A.,
Kalhs Peter,
Lechner Klaus,
Mannhalter Christine,
Moser Karin,
Worel Nina,
PircDanoewinata Hendrate,
Louda Norbert,
Loidolt Heidrun,
Rabitsch Werner,
Greinix Hildegard T.
Publication year - 2001
Publication title -
transfusion
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.045
H-Index - 132
eISSN - 1537-2995
pISSN - 0041-1132
DOI - 10.1046/j.1537-2995.2001.41010111.x
Subject(s) - leukapheresis , apheresis , myeloid leukemia , breakpoint cluster region , fluorescence in situ hybridization , chronic myelogenous leukemia , leukemia , medicine , immunology , biology , cancer research , stem cell , cd34 , platelet , genetics , receptor , gene , chromosome
BACKGROUND: Autografting of normal stem cells mobilized after chemotherapy is increasingly used in chronic myeloid leukemia (CML). Thus, quantification of possible contamination of progenitor cell apheresis with breakpoint cluster region (bcr)/Abelson murine leukemia ( abl)‐ positive cells is of great clinical interest. STUDY DESIGN AND METHODS: Two molecular methods were compared to quantify bcr/ abl positivity in leukapheresis components obtained after mobilizing chemotherapy in six patients with CML. To document the efficacy of in vivo purging, the leukapheresis procedures were monitored with interphase fluorescence in situ hybridization (FISH) and quantitative competitive PCR (QC‐PCR) as a ratio of bcr/ abl:abl . RESULTS: From the first to the last leukapheresis, bcr/ abl positivity in FISH increased from a median of 11 percent to 33 percent. For bcr/ abl transcripts, a simultaneous increase in consecutive leukapheresis procedures was seen. The median percentage of bcr cells in a bcr/ abl : abl ratio was 3.1 percent in the first apheresis. In the last apheresis after the mobilization with mRNA, the QC‐PCR showed a median of 19.5 percent. FISH and QC‐PCR showed a statistical significant increase of bcr/ abl positivity from the first to the last apheresis. CONCLUSIONS: Both FISH and QC‐PCR were reliable methods of quantifying bcr/ abl positivity, and they allowed selection of the optimal apheresis component for autologous transplantation. In both methods, a significant increase in bcr/ abl positivity was seen from the first to the last leukapheresis. With FISH, results can be obtained within 24 hours. This method may prevent additional contaminated leukapheresis in case of increasing percentages of bcr/ abl ‐positive cells.